Sangamo Therapeutics
SGMO
#6697
Rank
A$0.82 B
Marketcap
$3.95
Share price
6.93%
Change (1 day)
588.48%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2024 (TTM): -A$0.21 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are A$52.29 Million. In 2023 the company made an earning of -A$0.2 Billion, an increase over its 2022 earnings that were of -A$0.33 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.21 Billion5.8%
2023 -A$0.2 Billion-40.88%
2022 -A$0.33 Billion9.79%
2021 -A$0.3 Billion41.52%
2020 -A$0.21 Billion23.17%
2019 -A$0.17 Billion36.33%
2018 -A$0.13 Billion36.89%
2017 -A$90.15 Million-22.32%
2016 -A$0.12 Billion54.86%
2015 -A$74.95 Million75.62%
2014 -A$42.68 Million0.13%
2013 -A$42.62 Million
2011 -A$57.3 Million43.66%
2010 -A$39.89 Million28.52%
2009 -A$31.04 Million-23.55%
2008 -A$40.59 Million2.45%
2007 -A$39.62 Million19.5%
2006 -A$33.16 Million50.78%
2005 -A$21.99 Million75%
2004 -A$12.57 Million-33.25%
2003 -A$18.83 Million-62.27%
2002 -A$49.9 Million102.82%
2001 -A$24.6 Million23.21%
2000 -A$19.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$0.28 B-231.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.3 Billion 39.23%๐Ÿ‡บ๐Ÿ‡ธ USA
A$7.48 B-3,586.04%๐Ÿ‡บ๐Ÿ‡ธ USA
A$3.04 B-1,520.12%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.64 B-866.65%๐Ÿ‡บ๐Ÿ‡ธ USA
A$29.42 B-13,805.01%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.62 B-391.65%๐Ÿ‡บ๐Ÿ‡ธ USA
A$23.94 B-11,255.48%๐Ÿ‡บ๐Ÿ‡ธ USA